These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 23556549)
21. The efficacy of a combination of ondansetron, methylprednisolone and metopimazine in patients previously uncontrolled with a dual antiemetic treatment in cisplatin-based chemotherapy. The French Ondansetron Study Group. Lebeau B; Depierre A; Giovannini M; Rivière A; Kaluzinski L; Votan B; Hédouin M; d'Allens H Ann Oncol; 1997 Sep; 8(9):887-92. PubMed ID: 9358940 [TBL] [Abstract][Full Text] [Related]
23. Comparison of ondansetron with ondansetron plus dexamethasone for antiemetic prophylaxis in children undergoing strabismus surgery. Bhardwaj N; Bala I; Kaur C; Chari P J Pediatr Ophthalmol Strabismus; 2004; 41(2):100-4. PubMed ID: 15089065 [TBL] [Abstract][Full Text] [Related]
24. Chemotherapy-induced emesis: management of early and delayed emesis in milder emetogenic regimens. Barrenetxea G; Schneider J; Centeno MM; Romero H; de la Rica M; Rodríguez-Escudero FJ Cancer Chemother Pharmacol; 1996; 38(5):471-5. PubMed ID: 8765442 [TBL] [Abstract][Full Text] [Related]
25. Anaphylactoid Reactions to Intravenous N-Acetylcysteine during Treatment for Acetaminophen Poisoning. Yarema M; Chopra P; Sivilotti MLA; Johnson D; Nettel-Aguirre A; Bailey B; Victorino C; Gosselin S; Purssell R; Thompson M; Spyker D; Rumack B J Med Toxicol; 2018 Jun; 14(2):120-127. PubMed ID: 29423816 [TBL] [Abstract][Full Text] [Related]
26. Treatment of paracetamol overdose: room for improvement? Park K; Antoine DJ; Pirmohamed M Lancet; 2014 Feb; 383(9918):672-4. PubMed ID: 24290402 [No Abstract] [Full Text] [Related]
27. Modified oral ondansetron regimen for cyclophosphamide-induced emesis in lupus nephritis. Yarboro CH; Wesley R; Amantea MA; Klippel JH; Pucino F Ann Pharmacother; 1996; 30(7-8):752-5. PubMed ID: 8826554 [TBL] [Abstract][Full Text] [Related]
28. Treatment of paracetamol overdose--authors' reply. Bateman DN; Dear JW; Thanacoody HK; Thomas SH; Eddleston M Lancet; 2014 Apr; 383(9926):1383. PubMed ID: 24759248 [No Abstract] [Full Text] [Related]
29. Ondansetron for nausea and vomiting associated with moderately emetogenic cancer chemotherapy. DiBenedetto J; Cubeddu LX; Ryan T; Kish JA; Sciortino D; Beall C; Eisenberg PD; Henderson C; Griffin D; Wentz A Clin Ther; 1995; 17(6):1091-8. PubMed ID: 8750400 [TBL] [Abstract][Full Text] [Related]
30. Double-blind, randomized comparison of the antiemetic efficacy of intravenous dolasetron mesylate and intravenous ondansetron in the prevention of acute cisplatin-induced emesis in patients with cancer. Dolasetron Comparative Chemotherapy-induced Emesis Prevention Group. Hesketh P; Navari R; Grote T; Gralla R; Hainsworth J; Kris M; Anthony L; Khojasteh A; Tapazoglou E; Benedict C; Hahne W J Clin Oncol; 1996 Aug; 14(8):2242-9. PubMed ID: 8708713 [TBL] [Abstract][Full Text] [Related]
31. Paracetamol metabolite concentrations following low risk overdose treated with an abbreviated 12-h versus 20-h acetylcysteine infusion. Wong A; Homer N; Dear JW; Choy KW; Doery J; Graudins A Clin Toxicol (Phila); 2019 May; 57(5):312-317. PubMed ID: 30453788 [TBL] [Abstract][Full Text] [Related]
32. [Prevention of postoperative nausea and vomiting with single and repeat administration of ondansetron--review of the literature on different administration forms]. Saur P; Mühr C; Kazmaier S; Neumann P; Buhre W Anaesthesiol Reanim; 1996; 21(5):131-5. PubMed ID: 9044556 [TBL] [Abstract][Full Text] [Related]
33. Fewer adverse effects with a modified two-bag acetylcysteine protocol in paracetamol overdose. McNulty R; Lim JME; Chandru P; Gunja N Clin Toxicol (Phila); 2018 Jul; 56(7):618-621. PubMed ID: 29219630 [TBL] [Abstract][Full Text] [Related]
34. SNAPTIMED study: does the Scottish and Newcastle Antiemetic Protocol achieve timely intervention and management from the emergency department to discharge for paracetamol poisoning? Humphries C; Roberts G; Taheem A; Abdel Kader H; Kidd R; Smith J Emerg Med J; 2023 Mar; 40(3):221-223. PubMed ID: 35981856 [TBL] [Abstract][Full Text] [Related]
35. Stratified, randomized, double-blind comparison of intravenous ondansetron administered as a multiple-dose regimen versus two single-dose regimens in the prevention of cisplatin-induced nausea and vomiting. Beck TM; Hesketh PJ; Madajewicz S; Navari RM; Pendergrass K; Lester EP; Kish JA; Murphy WK; Hainsworth JD; Gandara DR J Clin Oncol; 1992 Dec; 10(12):1969-75. PubMed ID: 1453211 [TBL] [Abstract][Full Text] [Related]
36. A randomized study of aprepitant, ondansetron and dexamethasone for chemotherapy-induced nausea and vomiting in Chinese breast cancer patients receiving moderately emetogenic chemotherapy. Yeo W; Mo FK; Suen JJ; Ho WM; Chan SL; Lau W; Koh J; Yeung WK; Kwan WH; Lee KK; Mok TS; Poon AN; Lam KC; Hui EK; Zee B Breast Cancer Res Treat; 2009 Feb; 113(3):529-35. PubMed ID: 18327706 [TBL] [Abstract][Full Text] [Related]
37. Single-dose prophylaxis for postoperative nausea and vomiting after major abdominal surgery: ondansetron versus droperidol. Paech MJ; Pavy TJ; Evans SF Anaesth Intensive Care; 1995 Oct; 23(5):548-54. PubMed ID: 8787252 [TBL] [Abstract][Full Text] [Related]
38. An open-label dose comparison study of ondansetron for the prevention of emesis associated with chemotherapy prior to bone marrow transplantation. Osowski CL; Dix SP; Lynn M; Davidson T; Cohen L; Miyahara T; Sexauer MC; Joyce R; Yeager A; Wingard JR Support Care Cancer; 1998 Nov; 6(6):511-7. PubMed ID: 9833299 [TBL] [Abstract][Full Text] [Related]
39. The use of oral granisetron versus intravenous ondansetron for antiemetic prophylaxis in patients undergoing laparoscopic surgery: the effect on emetic symptoms and quality of recovery. White PF; Tang J; Hamza MA; Ogunnaike B; Lo M; Wender RH; Naruse R; Sloninsky A; Kariger R; Cunneen S; Khalili T Anesth Analg; 2006 May; 102(5):1387-93. PubMed ID: 16632815 [TBL] [Abstract][Full Text] [Related]
40. Continuous-infusion granisetron compared to ondansetron for the prevention of nausea and vomiting after high-dose chemotherapy. Kalaycio M; Mendez Z; Pohlman B; Overmoyer B; Boparai N; Jones E; Bolwell B J Cancer Res Clin Oncol; 1998; 124(5):265-9. PubMed ID: 9645457 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]